Cargando…
Impact of add-back FSH on human and mouse prostate following gonadotropin ablation by GnRH antagonist treatment
OBJECTIVE: During androgen ablation in prostate cancer by the standard gonadotropin-releasing hormone (GnRH) agonist treatment, only luteinizing hormone (LH) is permanently suppressed while circulating follicle-stimulating hormone (FSH) rebounds. We explored direct prostatic effects of add-back FSH,...
Autores principales: | Deiktakis, Eleftherios E, Ieronymaki, Eleftheria, Zarén, Peter, Hagsund, Agnes, Wirestrand, Elin, Malm, Johan, Tsatsanis, Christos, Huhtaniemi, Ilpo T, Giwercman, Aleksander, Giwercman, Yvonne Lundberg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254324/ https://www.ncbi.nlm.nih.gov/pubmed/35575351 http://dx.doi.org/10.1530/EC-21-0639 |
Ejemplares similares
-
Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017) -
Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023) -
GnRH antagonist treatment of malignant adrenocortical tumors
por: Doroszko, Milena, et al.
Publicado: (2018) -
Divergent expression patterns of pituitary gonadotropin subunit and GnRH receptor genes to continuous GnRH in vitro and in vivo
por: Janjic, Marija M., et al.
Publicado: (2019) -
Gonadotropin-releasing hormone (GnRH) stimulation test before and after GnRH analogue treatment in central precocious puberty; can GnRH test simplify adequately?
por: Yang, You Jean, et al.
Publicado: (2013)